Literature DB >> 21081186

The interactome of a PTB domain-containing adapter protein, Odin, revealed by SILAC.

Jun Zhong1, Raghothama Chaerkady, Kumaran Kandasamy, Marjan Gucek, Robert N Cole, Akhilesh Pandey.   

Abstract

Signal transduction pathways are tightly controlled by positive and negative regulators. We have previously identified Odin (also known as ankyrin repeat and sterile alpha motif domain-containing 1A; gene symbol ANKS1A) as a negative regulator of growth factor signaling; however, the mechanisms through which Odin regulates these pathways remain to be elucidated. To determine how Odin negatively regulates growth factor signaling, we undertook a proteomic approach to systematically identify proteins that interact with Odin using the SILAC strategy. In this study, we identified 18 molecules that were specifically associated in a protein complex with Odin. Our study established that the complete family of 14-3-3 proteins occur in a protein complex with Odin, which is also supported by earlier reports that identified a few members of the 14-3-3 family as Odin interactors. Among the novel protein interactors of Odin were CD2-associated protein, SH3 domain kinase binding protein 1 and DAB2 interacting protein. We confirmed 8 of the eighteen interactions identified in the Odin protein complex by co-immunoprecipitation experiments. Finally, a literature-based network analysis revealed that Odin interacting partners are involved in various cellular processes, some of which are key molecules in regulating receptor endocytosis.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21081186      PMCID: PMC3205450          DOI: 10.1016/j.jprot.2010.11.006

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  42 in total

1.  Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.

Authors:  Anne Benzinger; Nemone Muster; Heike B Koch; John R Yates; Heiko Hermeking
Journal:  Mol Cell Proteomics       Date:  2005-03-18       Impact factor: 5.911

2.  Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC).

Authors:  Ramars Amanchy; Dario E Kalume; Akiko Iwahori; Jun Zhong; Akhilesh Pandey
Journal:  J Proteome Res       Date:  2005 Sep-Oct       Impact factor: 4.466

3.  Identification of phosphotyrosine binding domain-containing proteins as novel downstream targets of the EphA8 signaling function.

Authors:  Jongdae Shin; Changkyu Gu; Eunjeong Park; Soochul Park
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

4.  A curated compendium of phosphorylation motifs.

Authors:  Ramars Amanchy; Balamurugan Periaswamy; Suresh Mathivanan; Raghunath Reddy; Sudhir Gopal Tattikota; Akhilesh Pandey
Journal:  Nat Biotechnol       Date:  2007-03       Impact factor: 54.908

5.  Genetic and biologic evidence that implicates a gene in aggressive prostate cancer.

Authors:  Jer-Tsong Hsieh; Jose A Karam; Wang Min
Journal:  J Natl Cancer Inst       Date:  2007-12-11       Impact factor: 13.506

6.  A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts.

Authors:  M L Dustin; M W Olszowy; A D Holdorf; J Li; S Bromley; N Desai; P Widder; F Rosenberger; P A van der Merwe; P M Allen; A S Shaw
Journal:  Cell       Date:  1998-09-04       Impact factor: 41.582

7.  Melatonin synthesis: 14-3-3-dependent activation and inhibition of arylalkylamine N-acetyltransferase mediated by phosphoserine-205.

Authors:  Surajit Ganguly; Joan L Weller; Anthony Ho; Philippe Chemineau; Benoit Malpaux; David C Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-11       Impact factor: 11.205

8.  Human protein reference database as a discovery resource for proteomics.

Authors:  Suraj Peri; J Daniel Navarro; Troels Z Kristiansen; Ramars Amanchy; Vineeth Surendranath; Babylakshmi Muthusamy; T K B Gandhi; K N Chandrika; Nandan Deshpande; Shubha Suresh; B P Rashmi; K Shanker; N Padma; Vidya Niranjan; H C Harsha; Naveen Talreja; B M Vrushabendra; M A Ramya; A J Yatish; Mary Joy; H N Shivashankar; M P Kavitha; Minal Menezes; Dipanwita Roy Choudhury; Neelanjana Ghosh; R Saravana; Sreenath Chandran; Sujatha Mohan; Chandra Kiran Jonnalagadda; C K Prasad; Chandan Kumar-Sinha; Krishna S Deshpande; Akhilesh Pandey
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

9.  Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.

Authors:  David Duggan; Siqun L Zheng; Michele Knowlton; Debbie Benitez; Latchezar Dimitrov; Fredrik Wiklund; Christiane Robbins; Sarah D Isaacs; Yu Cheng; Ge Li; Jielin Sun; Bao-Li Chang; Leslie Marovich; Kathleen E Wiley; Katarina Bälter; Pär Stattin; Hans-Olov Adami; Marta Gielzak; Guifang Yan; Jurga Sauvageot; Wennuan Liu; Jin Woo Kim; Eugene R Bleecker; Deborah A Meyers; Bruce J Trock; Alan W Partin; Patrick C Walsh; William B Isaacs; Henrik Grönberg; Jianfeng Xu; John D Carpten
Journal:  J Natl Cancer Inst       Date:  2007-12-11       Impact factor: 13.506

10.  Golgi-localized GAP for Cdc42 functions downstream of ARF1 to control Arp2/3 complex and F-actin dynamics.

Authors:  Thierry Dubois; Olivia Paléotti; Alexander A Mironov; Vincent Fraisier; Theresia E B Stradal; Maria Antonietta De Matteis; Michel Franco; Philippe Chavrier
Journal:  Nat Cell Biol       Date:  2005-03-27       Impact factor: 28.824

View more
  4 in total

1.  Odin (ANKS1A) modulates EGF receptor recycling and stability.

Authors:  Jiefei Tong; Yaroslav Sydorskyy; Jonathan R St-Germain; Paul Taylor; Ming S Tsao; Michael F Moran
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

2.  ProKinO: a unified resource for mining the cancer kinome.

Authors:  Daniel Ian McSkimming; Shima Dastgheib; Eric Talevich; Anish Narayanan; Samiksha Katiyar; Susan S Taylor; Krys Kochut; Natarajan Kannan
Journal:  Hum Mutat       Date:  2015-02       Impact factor: 4.878

3.  ANKS1B Interacts with the Cerebral Cavernous Malformation Protein-1 and Controls Endothelial Permeability but Not Sprouting Angiogenesis.

Authors:  Stefanie E Herberich; Ralph Klose; Iris Moll; Wan-Jen Yang; Joycelyn Wüstehube-Lausch; Andreas Fischer
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

4.  Anks1a regulates COPII-mediated anterograde transport of receptor tyrosine kinases critical for tumorigenesis.

Authors:  Haeryung Lee; Hyuna Noh; Jiyoung Mun; Changkyu Gu; Sanja Sever; Soochul Park
Journal:  Nat Commun       Date:  2016-09-13       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.